Oxford BioDynamics Plc (OBD.L)

8,20 -0,80 (-8,89%) Börsenschluss: 04:35PM BST

Oxford BioDynamics Plc

3140 Rowan Place
John Smith Drive Oxford Business Park South
Oxford OX4 2WB
United Kingdom
44 1865 518 910
https://www.oxfordbiodynamics.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 45

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.	CEO & Executive Director	606k	N/A	1962
Mr. Paul Leslie Stockdale F.C.A., M.A.	CFO & Executive Director	239k	N/A	1975
Dr. Alexandre Akoulitchev M.A., Ma (Oxon), Ph.D.	Chief Scientific Officer & Executive Director	276k	N/A	1962
Mr. Thomas G. Guiel B.A.	Chief Operating Officer	N/A	N/A	N/A
David Blum	Senior Vice President of Marketing	N/A	N/A	N/A
Dr. Steven Arrivo	Senior Vice President of Business & Corporate Development	N/A	N/A	N/A
Dr. Ewan Hunter B.Sc., Ph.D., Ph.D., (KCL)	Chief Data Officer	N/A	N/A	N/A
T. Demain	Company Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Corporate Governance

Oxford BioDynamics Plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.